Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

VEEV PEER ANALYSIS

Veeva Systems Inc Class A — metric-by-metric comparison with peers and the industry median

VEEVVeeva Systems Inc Class A

🇺🇸 USA · NYSE · Healthcare · Health Information Services

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Health Information Services

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
VEEVIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
VEEV-31.8%PME-31.5%
Year-to-Date (YTD)
VEEV-13.7%PME-4.8%
1-Year
Split-adjusted
VEEV-31.8%BTSG+213.8%HQY-5.9%TXG+199.8%WAY-39.3%DOCS-63.1%
Year-to-Date (YTD)
VEEV-13.7%BTSG+84.3%HQY+4.0%TXG+139.2%WAY-28.4%DOCS-50.6%

Key Metric Comparison

P/E

Lower is better
VEEV33.98PME93.49Median 41.96

ROE

Higher is better
VEEV13.9%PME76.8%Median 2.7%

Net Margin

Higher is better
VEEV28.4%PME97.6%Median 1.5%

Revenue Growth

Higher is better
VEEV16.2%PME30.3%Median 7.1%

P/E

Lower is better
VEEV33.98BTSG49.30HQY35.12TXG—WAY36.31DOCS21.75Median 41.96

ROE

Higher is better
VEEV13.9%BTSG16.9%HQY11.1%TXG-3.0%WAY3.6%DOCS19.3%Median 2.7%

Net Margin

Higher is better
VEEV28.4%BTSG2.3%HQY17.3%TXG-3.5%WAY10.9%DOCS30.4%Median 1.5%

Revenue Growth

Higher is better
VEEV16.2%BTSG21.0%HQY7.6%TXG2.3%WAY18.6%DOCS13.1%Median 7.1%

All Metrics

Valuation
MetricVEEVPMEInd. Median
P/E33.98●93.4941.96
P/B4.38●56.422.50
EV/EBITDA19.07●115.2416.12
P/S9.64●91.212.35
Financial Health
MetricVEEVPMEInd. Median
Current Ratio4.746.22●1.83
Debt/Equity1.4%1.1%●22.0%
NetDebt/EBITDA-5.55●-1.16-0.01
Profitability
MetricVEEVPMEInd. Median
Net Margin28.4%97.6%●1.5%
ROE13.9%76.8%●2.7%
ROA11.1%56.7%●1.4%
EBITDA Margin39.2%78.4%●12.4%
Growth + Dividend
MetricVEEVPMEInd. Median
Rev. Growth16.2%30.3%●7.1%
NI Growth20.6%138.8%●23.6%
Div. Yield—0.3%0.7%
Payout—24.5%9.6%
Valuation
MetricVEEVBTSGHQYTXGWAYDOCSInd. Median
P/E33.9849.3035.12—36.3121.75●41.96
P/B4.387.723.966.151.16●4.482.50
EV/EBITDA19.0732.4219.2448.7314.2713.25●16.12
P/S9.641.12●6.067.833.966.612.35
Financial Health
MetricVEEVBTSGHQYTXGWAYDOCSInd. Median
Current Ratio4.741.743.445.901.766.09●1.83
Debt/Equity1.4%136.4%48.1%10.0%37.7%1.1%●22.0%
NetDebt/EBITDA-5.55●3.441.57-4.913.21-2.78-0.01
Profitability
MetricVEEVBTSGHQYTXGWAYDOCSInd. Median
Net Margin28.4%2.3%17.3%-3.5%10.9%30.4%●1.5%
ROE13.9%16.9%11.1%-3.0%3.6%19.3%●2.7%
ROA11.1%5.1%6.9%-2.4%2.4%16.4%●1.4%
EBITDA Margin39.2%3.9%34.3%14.6%35.8%41.3%●12.4%
Growth + Dividend
MetricVEEVBTSGHQYTXGWAYDOCSInd. Median
Rev. Growth16.2%21.0%●7.6%2.3%18.6%13.1%7.1%
NI Growth20.6%441.5%●89.4%—383.6%-12.2%23.6%
Div. Yield——————0.7%
Payout——————9.6%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on VEEV

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.